The firm plans to build on its organ and tissue modeling technology to develop more sophisticated tests, including full-body digital twins.

The companies have been collaborating on the development of Kryptos' molecular tests, and Osang led Kryptos' $10 million financing round in 2024.

Kennesaw State University researcher Chen Zhao has earned the 2025 American Heart Association Institutional Research Enhancement Award (AIREA) for his unique research on non-invasive blood flow ...

Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin. This version is ...

Like recombinant DNA before it, gene editing has the potential to transform medicine, agriculture and more. CRISPR is now used by thousands of biologists in labs across the globe. A revolution in food ...

Through this platform, resistance in bacterial samples can be tested within two hours compared to 24-27 hours through other ...

Traditional diagnostic methods, such as bacterial culture and PCR-based testing, can take 24–72 hours, delaying critical ...

Antimicrobial resistance (AMR) is a critical global health challenge, requiring early and accurate detection of resistance ...

Market OverviewThe global Molecular Diagnostics Market is valued at USD 14.9 Billion in 2022 and is projected to reach a ...

The global Gene Editing Market was valued at $5.1 billion in 2022 and is projected to reach $16.2 billion by 2030, growing at ...

The CRISPR-Cas gene scissors offer a wide range of potential applications, from the treatment of genetic diseases to ...